These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 2432917

  • 1. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
    Sie P, Ofosu F, Fernandez F, Buchanan MR, Petitou M, Boneu B.
    Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917
    [Abstract] [Full Text] [Related]

  • 2. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
    Ofosu FA, Blajchman MA, Modi GJ, Smith LM, Buchanan MR, Hirsh J.
    Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
    Scully MF, Ellis V, Seno N, Kakkar VV.
    Biochem J; 1988 Sep 01; 254(2):547-51. PubMed ID: 2902851
    [Abstract] [Full Text] [Related]

  • 7. Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharides.
    Wun TC.
    Blood; 1992 Jan 15; 79(2):430-8. PubMed ID: 1346095
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Involvement of antithrombin III in anticoagulant effects of sulphated polysaccharides [proceedings].
    Kindness G, Williamson FB, Long WF.
    Biochem Soc Trans; 1980 Feb 15; 8(1):82-3. PubMed ID: 6154613
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM, Barrowcliffe TW, Thomas DP.
    Thromb Haemost; 1982 Apr 30; 47(2):104-8. PubMed ID: 6179182
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA.
    Nouv Rev Fr Hematol (1978); 1988 Apr 30; 30(3):155-60. PubMed ID: 2971155
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison between the effect of pentosan polysulphate heparin and antithrombin III injections in antithrombin III deficient patients.
    Fischer AM, Dautzenberg MD, Aurousseau MH, Béguin S, Goudemand J, Hemker HC.
    Thromb Res; 1985 Jan 15; 37(2):295-307. PubMed ID: 2579452
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.